2seventy Bio Shares Are Trading Higher After the Company Announced the Sale of Its Hemophilia A Candidate and MegaTAL to Novo Nordisk.
2seventy Bio Shares Are Trading Higher After the Company Announced the Sale of Its Hemophilia A Candidate and MegaTAL to Novo Nordisk.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.